Delivery Order SPE2DB24D9228-SPE2DB25FATHJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on August 5, 2025, for the supply of YF-VAX 1 dose vials with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a straightforward pharmaceutical procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order employs firm fixed-price terms and represents a standard procurement action within the agency's pharmaceutical supply operations....
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials. The contract is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and was executed on July 28, 2025. The award was issued without a set-aside designation, leveraging open competition. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under DMS's existing $499.999 billion Indefinite Delivery Contract with DLA through the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials. This delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a purchase of yellow fever vaccine product to support federal healthcare requirements. The award carries no set-aside designation and will be performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,186.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The award, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $2,226.84 for YF-VAX 1 dose vials with an ultimate completion date of August 26, 2025. This delivery order was issued without a set-aside designation and represents a discrete procurement action under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a $15,031.17 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 21, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, Illinois, and represents a continuation of the company's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,783.55 by the Defense Logistics Agency on July 25, 2025, for YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November...
- SPE2DB24D9228Indefinite Delivery Contract
- SPE2DB24D9228-SPE2DB25FATHJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies for military health facilities. The work will be performed in Park Ridge, Illinois, where the vendor is headquartered. No set-aside designation was applied to this procurement. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has established itself as a critical supplier within the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare systems nationwide. YF-VAX is a yellow fever vaccine used for immunization purposes, and this delivery order represents one of many vaccine and pharmaceutical products the vendor regularly supplies through its DLA contract portfolio. The company's consistent receipt of delivery orders without set-aside designations demonstrates its competitive positioning in federal procurement markets based on its business classification and service capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/5/25 |